FDA Approves New Tau PET Tracer for Alzheimer's Disease
August 14, 2026
August 14, 2026
RESTON, Virginia, Aug. 14 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
FDA Approves New Tau PET Tracer for Alzheimer's Disease
*
The U.S. Food and Drug Administration has approved florquinitau F-18 injection (Tauklarify; Lantheus) for PET imaging of the brain in adults with cognitive impairment undergoing evaluation for Alzheimer's disease, adding a second FDA-ap . . .
* * *
FDA Approves New Tau PET Tracer for Alzheimer's Disease
*
The U.S. Food and Drug Administration has approved florquinitau F-18 injection (Tauklarify; Lantheus) for PET imaging of the brain in adults with cognitive impairment undergoing evaluation for Alzheimer's disease, adding a second FDA-ap . . .